Mohamed Abdel-Wahab

Showing 1-20 of 26 articles

Coronary interventions

Bioresorbable Vascular Scaffold Versus Metallic Drug-Eluting Stent in Patients at High Risk of Restenosis: The COMPARE-ABSORB Randomized Clinical Trial

Smits P, Chang C, Chevalier B, West N, Gori T, Barbato E, Tarantini G, Kocka V, Achenbach S, Dudek D, Escaned J, Włodarczak A, Abdel-Wahab M, Esposito G, Tijssen J, Morice M, Onuma Y, van Geuns R

May 26, 2020 | 10.4244/EIJ-D-19-01079

Long-term follow-up of patients with contained annulus ruptures after TAVI: the EuropeaN COntained RupturE (ENCORE) registry

Breitbart P, Minners J, Pache G, Hansson N, Nørgaard B, De Backer O, Søndergaard L, Alsanjari O, Hildick-Smith D, Abdel-Wahab M, Löbig S, Neumann F, Ruile P

May 20, 2020 | 10.4244/EIJ-D-19-00740

Coronary interventions

Fractional Flow Reserve-Guided Multivessel Angioplasty in Myocardial Infarction: 3-year follow-up with cost benefit analysis of the Compare-Acute trial

Smits P, Laforgia PL, Abdel-Wahab M, Neumann F, Richardt G, Boxma-de Klerk B, Lunde K, Schotborgh CE, Piroth Z, Horak D, Wlodarczak A, Frederix GW, Omerovic E, Ong PJ, Hambrecht R, Angeras O

April 7, 2020 | 10.4244/EIJ-D-20-00012

Interventions for valvular disease

Long-term follow-up of patients with Contained Annulus Ruptures after TAVI: the EuropeaN COntained RupturE ENCORE-registry

Breitbart P, Minners J, Pache G, Hansson N, Nørgaard BL, De Backer O, Søndergaard L, Alsanjari O, Hildick-Smith D, Abdel-Wahab M, Löbig S, Neumann F, Ruile P

February 4, 2020 | 10.4244/EIJ-D-19-00740

Interventions for valvular disease

Quantitative aortography assessment of aortic regurgitation. Insight into a novel technique

Modolo R, Chang C, Onuma Y, Schultz C, Tateishi H, Abdelghani M, Miyazaki Y, Aben J-P, Rutten M, Pighi M, El Bouziani A, van Mourik M, Lemos P, Wykrzykowska J, Sandoli de Brito Jr F, Sahyoun C, Piazza N, Eltchaninoff H, Soliman O, Abdel-Wahab M, Van Mieghem N, de Winter R, Serruys P

November 20, 2019 | 10.4244/EIJ-D-19-00879

TAVI and horizontal aorta: a "no impact" relationship?

Abdel-Wahab M, Kitamura M, Thiele H

October 4, 2019 | 10.4244/EIJV15I9A136

Coronary interventions

Impact of target lesion location on procedural and angiographic outcomes of rotational atherectomy versus modified balloon angioplasty prior to drug-eluting stent implantation in severely calcified coronary lesions:a subgroup analysis of the PREPARE-CALC randomized trial

Rheude T, Toelg R, Byrne R, Allali A, Wiebe J, Sulimov D, Voll F, Cassese S, Richardt G, Kastrati A, Abdel-Wahab M

October 1, 2019 | 10.4244/EIJ-D-19-00488

Quantitative aortography for assessing aortic regurgitation after transcatheter aortic valve implantation: results of the multicentre ASSESS-REGURGE Registry

Modolo R, Chang C, Tateishi H, Miyazaki Y, Pighi M, Abdelghani M, Roos M, Wolff Q, Wykrzykowska J, de Winter R, Piazza N, Richardt G, Abdel-Wahab M, Soliman O, Onuma Y, Van Mieghem N, Serruys P

August 29, 2019 | 10.4244/EIJ-D-19-00362

TAVI and valve performance: update on definitions, durability, transcatheter heart valve failure modes and management

Eltchaninoff H, Durand E, Barbanti M, Abdel-Wahab M

September 7, 2018 | 10.4244/EIJ-D-18-00653

Interventions for valvular disease

Computed tomography-based oversizing and incidence of paravalvular aortic regurgitation and permanent pacemaker implantation with a new-generation self-expanding transcatheter heart valve

Kim U, Blanke P, Windecker S, Kasel A, Schäfer U, Walters D, Linke A, Le Breton H, Schymik G, Spence M, Søndergaard L, Abdel-Wahab M, Worthley S, Tchétché D, Reichenspurner H, Ohana M, Sellers S, Leipsic J

August 3, 2018 | 10.4244/EIJ-D-17-01040

Interventions for valvular disease

Long-term durability and haemodynamic performance of a self-expanding transcatheter heart valve beyond five years after implantation: a prospective observational study applying the standardised definitions of structural deterioration and valve failure

Holy E, Kebernik J, Abdelghani M, Stampfli SF, Hellermann J, Allali A, El-Mawardy M, Sachse S, Lüscher T, Tanner F, Richardt G, Abdel-Wahab M

July 20, 2018 | 10.4244/EIJ-D-18-00041

Interventions for valvular disease

Transcatheter aortic valve implantation with the 34 mm self-expanding CoreValve Evolut R: initial experience in 101 patients from a multicentre registry

Kuhn C, Frerker C, Meyer A-K, Kurz T, Schäfer U, Deuschl F, Abdel-Wahab M, Schewel D, Elghalban A, Kuck K, Frey N, Frank D

June 14, 2018 | 10.4244/EIJ-D-17-01153

Interventions for valvular disease

Impact of femoral artery puncture using digital subtraction angiography and road mapping on vascular and bleeding complications after transfemoral transcatheter aortic valve implantation

El-Mawardy M, Schwarz B, Landt M, Sulimov DS, Kebernik J, Allali A, Becker B, Toelg R, Richardt G, Abdel-Wahab M

January 20, 2017 | 10.4244/EIJ-D-15-00412

Interventions for valvular disease

One-year outcomes with two suture-mediated closure devices to achieve access-site haemostasis following transfemoral transcatheter aortic valve implantation

Mehilli J, Jochheim D, Abdel-Wahab M, Rizas K, Theiss H, Spenkuch N, Zadrozny M, Baquet M, El-Mawardy M, Sato T, Lange P, Kupatt C, Greif M, Hausleiter J, Bauer A, Schwarz F, Pichlmaier M, Hagl C, Richardt G, Massberg S

November 20, 2016 | 10.4244/EIJV12I10A213

Interventions for valvular disease

Redo TAVI: initial experience at two German centres

Schmidt T, Frerker C, Alessandrini H, Schlüter M, Kreidel F, Schäfer U, Thielsen T, Kuck K, Jose J, Holy E, El-Mawardy M, Allali A, Richardt G, Abdel-Wahab M

September 18, 2016 | 10.4244/EIJV12I7A144

Coronary interventions

Incidence and predictors of unplanned non-target lesion revascularisation up to three years after drug-eluting stent implantation: insights from a pooled analysis of the RESOLUTE Global Clinical Trial Program

Abdel-Wahab M, Neumann F, Serruys P, Silber S, Leon M, Mauri L, Yeung A, Belardi J, Widimsky P, Meredith I, Saito S, Richardt G

July 20, 2016 | 10.4244/EIJY15M07_07

Coronary interventions

Hybrid strategy with a bioresorbable scaffold and a drug-coated balloon for diffuse coronary artery disease: the “no more metallic cages” multicentre pilot experience

Ielasi A, Miyazaki T, Geraci S, Testa L, Abdel-Wahab M, Kawamoto H, Ruparelia N, Sato T, Caramanno G, Bedogni F, Tespili M, Colombo A, Latib A

April 8, 2016 | 10.4244/EIJV11I14A309

Interventions for valvular disease

Transfemoral TAVI devices: design overview and clinical outcomes

Abdel-Wahab M, Jose J, Richardt G

September 17, 2015 | 10.4244/EIJV11SWA33

Selection of TAVI prostheses: do we really have the CHOICE?

Abdel-Wahab M, Richardt G

September 27, 2014 | 10.4244/EIJV10SUA5

Comparison of bivalirudin and heparin in patients undergoing rotational atherectomy: a subanalysis of the randomised ROTAXUS trial

Akin I, Khattab A, Buettner H, Toelg R, Geist V, Neumann F, Richardt G, Abdel-Wahab M

August 19, 2014 | 10.4244/EIJV10I4A79

Latest news

NEW ISSUE

LM revascularisation, annulus rupture, risk stratification, renal denervation

May 20, 2020

NEW

Ahead of print: The Impact of COVID-19 on Interventional Cardiology Practice: Results of the EAPCI Survey

Marco Roffi, Dariusz Dudek, et al.

June 3, 2020

Editorial

A perspective from EAPCI Women and Women as One

Gill Louise Buchanan

June 3, 2020

Trials Book

Last Update: CULPRIT, NOBEL, IVUS-XPL, SAFARI-STEMI

(supported by Biotronik)

May 14, 2020

Guidance Papers

Guidelines, consensus & position papers

May 14, 2019

NEW

EuroIntervention new Editorial Board

June 3, 2020

JAA

This week’s JAA’s: Paradigm Study: 12months outcome, GLASSY ACS vs SIHD...

June 2, 2020

Mohamed Abdel-Wahab

Latest news

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke